Atm Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Atm Antibodies for various research applications. Atm Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Ataxia-telangiectasia mutated (ATM) is a critical protein involved in the cellular response to DNA damage, playing a key role in maintaining genomic stability. ATM is essential for the activation of DNA repair pathways and is implicated in cell cycle regulation. Mutations in the ATM gene are associated with ataxia-telangiectasia, a disorder characterized by neurodegeneration, immunodeficiency, and increased cancer risk. ATM signaling pathways are crucial for understanding cellular responses to DNA damage and potential therapeutic interventions. Research utilizing ATM monoclonal antibodies has revealed significant insights into DNA damage response mechanisms and cell cycle checkpoints. Investigating ATM's role in various cellular processes continues to advance our understanding of cancer biology and genetic disorders. Santa Cruz Biotechnology monoclonal antibodies for ATM research support scientists in advancing knowledge of DNA damage response pathways and potential therapeutic strategies.